Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study.

NCT05841719
unknown

Comparison of Three Frailty Screening Tools

NCT04835090
completednot_applicable

SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia

NCT02486185
completednot_applicable

Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary Syndromes

NCT02324660
completedphase_3

Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention

NCT01014026

Clinical Trials (5)

Showing 5 of 5 trials
NCT05841719Not Applicable

Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study.

Completed
NCT04835090

Comparison of Three Frailty Screening Tools

Unknown
NCT02486185Not Applicable

SARCORSICA: SARC-F Questionnaire as a Screening Tool for Age-related Sarcopenia

Completed
NCT02324660Not Applicable

Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary Syndromes

Completed
NCT01014026Phase 3

Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5